Stay updated on PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.

Latest updates to the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new funding source line (2016 U.S. NIH Grant/Contract) is added to the study identifiers, and the page revision is updated to v3.6.6.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now lists Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor update to the page's revision metadata.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.6.4 is now displayed, replacing v3.6.3. This indicates a new version of the page source rather than a change to study details or functionality.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, reflecting a new version of the page.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page.SummaryDifference0.0%

- Check94 days agoChange DetectedAdded new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment-status note ('No longer looking for participants'), improving visibility and user flow. The Intervention header was updated from 'Intervention / Treatment' to 'Intervention/Treatment' and the page revision tag updated to v3.6.0, while the old label was removed.SummaryDifference0.4%

Stay in the know with updates to PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.